Advocates, some AGs wary of Purdue Pharma bankruptcy plan
OxyContin maker Purdue Pharma has a $10 billion plan to transform into a new company dedicated to fighting the opioid crisis, but it's not a done deal yet. |!| Portland
OxyContin maker Purdue Pharma has a $10 billion plan to transform into a new company dedicated to fighting the opioid crisis, but it's not a done deal yet. |!| Portland